Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions

MLA

Nathalie M. Vandevelde, et al. “Belgian Rare Diseases Plan in Clinical Pathology: Identification of Key Biochemical Diagnostic Tests and Establishment of Reference Laboratories and Financing Conditions.” Orphanet Journal of Rare Diseases, vol. 16, no. 1, Feb. 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13023-021-01728-1.

APA

Nathalie M. Vandevelde, Pieter Vermeersch, Katrien M. J. Devreese, Marie-Françoise Vincent, Béatrice Gulbis, François Eyskens, François Boemer, André Gothot, Viviane O. Van Hoof, Carolien Bonroy, Hedwig Stepman, Geert A. Martens, Xavier Bossuyt, Laurence Roosens, Julie Smet, Hilde Laeremans, Ilse Weets, Jean-Marc Minon, Kris Vernelen, … Advisory Board of the Action 1 of the Belgian National Plan for Rare Diseases. (2021). Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions. Orphanet Journal of Rare Diseases, 16(1), 1–16. https://doi.org/10.1186/s13023-021-01728-1

Chicago

Nathalie M. Vandevelde, Pieter Vermeersch, Katrien M. J. Devreese, Marie-Françoise Vincent, Béatrice Gulbis, François Eyskens, François Boemer, et al. 2021. “Belgian Rare Diseases Plan in Clinical Pathology: Identification of Key Biochemical Diagnostic Tests and Establishment of Reference Laboratories and Financing Conditions.” Orphanet Journal of Rare Diseases 16 (1): 1–16. doi:10.1186/s13023-021-01728-1.